Dr. Kamitaki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
125 Paterson Street
Suite 6100
New Brunswick, NJ 08901Phone+1 732-235-7340Fax+1 732-235-7041
Summary
- I am currently an assistant professor of neurology at Rutgers-Robert Wood Johnson Medical School. I have an active clinical practice as a board-certified neurologist and epileptologist. I am also a faculty preceptor for neurology residents in their outpatient general neurology continuity clinic. My research interests include health services research, epidemiology, and addressing health disparities in epilepsy. Additionally, I serve as co-director of the Health Equity Thread for medical students at RWJMS.
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Epilepsy, 2016 - 2018
- New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 2013 - 2016
- New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 2012 - 2013
- University of Hawaii, John A. Burns School of MedicineClass of 2012
Certifications & Licensure
- NJ State Medical License 2018 - 2025
- NY State Medical License 2015 - 2023
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Epilepsy
Publications & Presentations
PubMed
- Crowdsourcing Adverse Events Associated With Monoclonal Antibodies Targeting Calcitonin Gene-Related Peptide Signaling for Migraine Prevention: Natural Language Proces...Pengfei Zhang, Brad K Kamitaki, Thien Phu Do
JMIR Formative Research. 2024-11-08 - Health insurance and transportation barriers impact access to epilepsy care in the United States.Brad K Kamitaki, Shelly Maniar, Raaga Rambhatla, Kelly Gao, Joel C Cantor
Epilepsy Research. 2024-09-01 - 4 citationsAn exploratory study evaluating the 30 medications most commonly associated with headaches in the FDA Adverse Event Reporting System.Brett Musialowicz, Brad Kamitaki, Pengfei Zhang
Headache. 2023-02-01
Journal Articles
- Epilepsy in the elderly: Risk factors and management approachesKamitaki Brad K., Choi, Hyunmi, Current Geriatrics Reports, 3/2018
Press Mentions
- RWJBarnabas Health Institute for Prevention and Recovery to Take Part in New Research Center to End Opioid AddictionNovember 10th, 2022
- EEG Helps Predict if Treatment Will Benefit People with EpilepsyOctober 29th, 2021
- Research Delivers Hope for Epilepsy PatientsOctober 28th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: